Cargando…

Infection- or vaccine mediated immunity reduces SARS-CoV-2 transmission, but increases competitiveness of Omicron in hamsters

Omicron has demonstrated a competitive advantage over Delta in vaccinated people. To understand this, we designed a transmission chain experiment using naïve, intranasally (IN) or intramuscularly (IM) vaccinated, and previously infected (PI) hamsters. Vaccination and previous infection protected ani...

Descripción completa

Detalles Bibliográficos
Autores principales:	Port, Julia R., Yinda, Claude Kwe, Riopelle, Jade C., Weishampel, Zachary A., Saturday, Taylor A., Avanzato, Victoria A., Schulz, Jonathan E., Holbrook, Myndi G., Barbian, Kent, Perry-Gottschalk, Rose, Haddock, Elaine, Martens, Craig, Shaia, Carl. I., Lambe, Teresa, Gilbert, Sarah C., van Doremalen, Neeltje, Munster, Vincent J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387121/ https://www.ncbi.nlm.nih.gov/pubmed/35982658 http://dx.doi.org/10.1101/2022.07.29.502072

Ejemplares similares

Infection- or AZD1222 vaccine-mediated immunity reduces SARS-CoV-2 transmission but increases Omicron competitiveness in hamsters
por: Port, Julia R., et al.
Publicado: (2023)

Host and viral determinants of airborne transmission of SARS-CoV-2 in the Syrian hamster
por: Port, Julia R., et al.
Publicado: (2023)

Increased aerosol transmission for B.1.1.7 (alpha variant) over lineage A variant of SARS-CoV-2
por: Port, Julia, et al.
Publicado: (2021)

SARS-CoV-2 disease severity and transmission efficiency is increased for airborne compared to fomite exposure in Syrian hamsters
por: Port, Julia R., et al.
Publicado: (2021)

Increased aerosol transmission for B.1.1.7 (alpha variant) over lineage A variant of SARS-CoV-2
por: Port, Julia R., et al.
Publicado: (2021)

SARS-CoV-2 disease severity and transmission efficiency is increased for airborne but not fomite exposure in Syrian hamsters.
por: Port, Julia R., et al.
Publicado: (2020)

Prior aerosol infection with lineage A SARS-CoV-2 variant protects hamsters from disease, but not reinfection with B.1.351 SARS-CoV-2 variant
por: Yinda, Claude Kwe, et al.
Publicado: (2021)

OraSure InteliSwab(®) Rapid Antigen Test performance with the SARS-CoV-2 Variants of Concern Alpha, Beta, Gamma, Delta, and Omicron
por: Weishampel, Zachary A., et al.
Publicado: (2022)

OraSure InteliSwab(™) Rapid Antigen Test Performance with the SARS-CoV-2 Variants of Concern—Alpha, Beta, Gamma, Delta, and Omicron
por: Weishampel, Zachary A., et al.
Publicado: (2022)

ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7
por: Fischer, Robert J., et al.
Publicado: (2021)

ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7
por: Fischer, Robert J., et al.
Publicado: (2021)

Efficacy of ChAdOx1 vaccines against SARS-CoV-2 Variants of Concern Beta, Delta and Omicron in the Syrian hamster model
por: van Doremalen, Neeltje, et al.
Publicado: (2022)

UV-C light completely blocks highly contagious Delta SARS-CoV-2 aerosol transmission in hamsters
por: Fischer, Robert J., et al.
Publicado: (2022)

UV-C Light Completely Blocks Aerosol Transmission of Highly Contagious SARS-CoV-2 Variants WA1 and Delta in Hamsters
por: Fischer, Robert J., et al.
Publicado: (2022)

ChAdOx1 nCoV-19 (AZD1222) or nCoV-19-Beta (AZD2816) protect Syrian hamsters against Beta Delta and Omicron variants
por: van Doremalen, Neeltje, et al.
Publicado: (2022)

K18-hACE2 mice develop respiratory disease resembling severe COVID-19
por: Yinda, Claude Kwe, et al.
Publicado: (2020)

K18-hACE2 mice develop respiratory disease resembling severe COVID-19
por: Yinda, Claude Kwe, et al.
Publicado: (2021)

Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces shedding of SARS-CoV-2 D614G in rhesus macaques
por: van Doremalen, Neeltje, et al.
Publicado: (2021)

Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models
por: van Doremalen, Neeltje, et al.
Publicado: (2021)

SARS-CoV-2 Omicron BA.1 and BA.2 are attenuated in rhesus macaques as compared to Delta
por: van Doremalen, Neeltje, et al.
Publicado: (2022)

SARS-CoV-2 Omicron BA.1 and BA.2 are attenuated in rhesus macaques as compared to Delta
por: van Doremalen, Neeltje, et al.
Publicado: (2022)

Western diet increases COVID-19 disease severity in the Syrian hamster
por: Port, Julia R., et al.
Publicado: (2021)

Severe acute respiratory disease in American mink experimentally infected with SARS-CoV-2
por: Adney, Danielle R., et al.
Publicado: (2022)

The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters
por: Carroll, Timothy, et al.
Publicado: (2021)

The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters
por: Carroll, Timothy, et al.
Publicado: (2022)

High-Fat High-Sugar Diet-Induced Changes in the Lipid Metabolism Are Associated with Mildly Increased COVID-19 Severity and Delayed Recovery in the Syrian Hamster
por: Port, Julia R., et al.
Publicado: (2021)

Stability of Monkeypox Virus in Body Fluids and Wastewater
por: Yinda, Claude Kwe, et al.
Publicado: (2023)

A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters
por: van Doremalen, Neeltje, et al.
Publicado: (2019)

Comparative Aerosol and Surface Stability of SARS-CoV-2 Variants of Concern
por: Bushmaker, Trenton, et al.
Publicado: (2023)

Subtle differences in the pathogenicity of SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in rhesus macaques
por: Munster, Vincent J., et al.
Publicado: (2021)

Updated and Validated Pan-Coronavirus PCR Assay to Detect All Coronavirus Genera
por: Holbrook, Myndi G., et al.
Publicado: (2021)

ChAdOx1 NiV vaccination protects against lethal Nipah Bangladesh virus infection in African green monkeys
por: van Doremalen, Neeltje, et al.
Publicado: (2022)

Atypical and Unique Transmission of Monkeypox Virus during the 2022 Outbreak: An Overview of the Current State of Knowledge
por: Riopelle, Jade C., et al.
Publicado: (2022)

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
por: Williamson, Brandi N., et al.
Publicado: (2020)

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
por: Williamson, Brandi N., et al.
Publicado: (2020)

Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model
por: Rosenke, Kyle, et al.
Publicado: (2021)

Immunogenicity of Low-Dose Prime-Boost Vaccination of mRNA Vaccine CV07050101 in Non-Human Primates
por: van Doremalen, Neeltje, et al.
Publicado: (2021)

Immunogenicity of low dose prime-boost vaccination of mRNA vaccine CV07050101 in non-human primates
por: van Doremalen, Neeltje, et al.
Publicado: (2021)

Effect of Environmental Conditions on SARS-CoV-2 Stability in Human Nasal Mucus and Sputum
por: Matson, M. Jeremiah, et al.
Publicado: (2020)

Histopathologic Characterization of Experimental Peracute SARS-CoV-2 Infection in the Syrian Hamster
por: Clancy, Chad S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cbh3ka21o9fva3kugpc38gmn2h